Microbial/enzymatic synthesis of chiral drug intermediates

Advances in Applied Microbiology

Volumn 47, Issue , 2000, Pages 33-78

  Patel, Ramesh N ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; ACETAL DERIVATIVE; ACETOPHENONE DERIVATIVE; ALCOHOL DERIVATIVE; AMIDE; ANTIHYPERTENSIVE AGENT; ANTIVIRUS AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BMS 186318; BMS 188494; CARBOXYLIC ACID DERIVATIVE; COMPACTIN; CYTOCHROME P450; DIPEPTIDE; DISULFIDE; EPOXIDE; ESTER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYPOCHOLESTEROLEMIC AGENT; MICROBIAL ENZYME; NORLEUCINE; OMAPATRILAT; OXIDOREDUCTASE; OXOACID; PRAVASTATIN; SOLVENT; SQUALENE SYNTHASE; SQUALENE SYNTHASE INHIBITOR; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; DRUG; ENZYME; GUANIDINE DERIVATIVE;

AMINATION; BIOTRANSFORMATION; CHIRALITY; FERMENTATION; HYDROLYSIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MICROORGANISM; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; RACEMIC MIXTURE; REDUCTION; REVIEW; SYNTHESIS; CATALYSIS; CHEMISTRY; METABOLISM; STEREOISOMERISM;

CANDIDA ANTARCTICA; CANDIDA BOIDINII; ESCHERICHIA COLI; SUIDAE; SUS SCROFA;

ADRENERGIC BETA-AGONISTS; ANTICHOLESTEREMIC AGENTS; ANTIHYPERTENSIVE AGENTS; ANTIVIRAL AGENTS; CATALYSIS; ENZYMES; FERMENTATION; GUANIDINES; PHARMACEUTICAL PREPARATIONS; STEREOISOMERISM;

EID: 0033792762     PISSN: 00652164     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0065-2164(00)47001-2     Document Type: Review

References (22)

1. Allen, J. V., and Williams, J. M. J. (1996). Dynamic kinetic resolution with enzyme and palladium combinations. Tetrahedron Lett. 37, 1859-1862.
2. Arch, J. R. S. (1997). β3-adrenoceptors and other putative atypical β-adrenoceptors. Pharmacol. Rev. Commun. 9, 141-148.
3. Arch, J. R. S., Ainsworth, A. T., Cawthrone, M. A., Piercy, V., Sennitt, M. V., Thody, V. E., Wilson, C., and Wilson, S. (1984). Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature 309, 163-165.
4. Audia, J. E., Britton, T. C., Droste, J. J., Folmer, B. K., Huffman, G. W., Varghese, J., Latimar, L. H., Mabry, T. E., and Nissen, J. S. (1996). "Preparation of N-(Phenylacetyl)di- and Tripeptide Derivatives for Inhibiting β-Amyloid Peptide Release." U.S. Patent 96-755442.
5. Baroni, M., Cecchi, R., and Croci, T. (1994). "Synthesis of β-3 Receptor Agonists." European Patent Application 626367 A1941130.
6. Barrish, J. C., Gordon, E., Alam, M., Lin, P.-F., Bisacchi, G. S., Cheng, P. T. W., Fritz, A. W., Greytok, J. A., Hermsmeier, M. A., Humphreys, W. G., Lis, K. A., Marella, M. A., Merchant, Z., Mitt, T., Morrison, R. A., Obermeier, M. T., Pluscec, J., Skoog, M., Slusarchyk, W. A., Spergel, S. Stevenson, J. M., Sun, C. Q., Sundeen, J. E., Taunk, P., Tino, J. A., Warrack, B. M., Colono, R., and Zahler, R. (1994). Aminodiol HIV protease inhibitors, 1: Design, synthesis, and preliminary SAR. J. Med. Chem. 37, 1758-1771.
7. Biller, S. A., and Majnin, D. (1995). "Preparation of α-Phosphonoalkanoates as Squalene Synthase Inhibitors." U.S. Patent 95-5428028.
8. Biller, S. A., Sofia, M. J., DeLange, B., Foster, C., Gordon, E. M., Harrity, T., Rich, L. C., and Ciosek, C. P. (1991a). The first potent inhibitor of squalene synthase: A profound contribution of an ether oxygen to inhibitor-enzyme interaction. J. Am. Chem. Soc. 113, 8522-8527.
9. Biller, S. A., Foster, C., Gordon, E. M., Harrity, T., Rich, L. C., Maretta, J., and Ciosek, C. P. (1991b). Isoprenyl phosphinylformates: New inhibitors of squalene synthase. J. Med. Chem. Soc. 34, 1912-1918.
10. Bloom, J. D., Datta, M. D., Johnson, B. D., Wissner, A., Bruns, M. G., Largis, E. E., Dolan, J. A., and Claus, T. H. (1989). Disodium (R,R)5-[2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2- dicarboxylate: A potent β-adrenergic agonist virtually specific for β3 receptors. J. Med. Chem. 35, 3081-3084.
11. Bodanszky, M., Martinez, J., Priestly, G. P., Gardner, J. D., and Mutt, V. (1978). Synthesis and properties of a biologically active analog of the C-terminal heptapeptide with e-hydroxynorleucine sulfate replacing tyrosine sulfate. J. Med. Chem. 21, 1030-1035.
12. Bommarius, A. S. (1995). In "Enzyme Catalysis in Organic Synthesis" (K. Drauz and H. Waldmann, ed.), Vol. 2, pp. 633-641. VCH, Weinheim.
13. Buisson, D., Azerad, R., Sanner, C., and Larcheveque, M. (1992). A study of the stereo-controlled reduction of aliphatic β-ketoesters by Geotrichum candidum. Biocatatysis 5, 249-265.
14. Catt, J. D., Johnson, G., Keavy, D. J., Mattson, R. J., Parker, M. F. Takaki, K. S., and Yevich, J. P. (1998). PCT International Application WO98/25606.
15. Catt, J. D., Johnson, G., Keavy, D. J., Mattson, R. J., Parker, M. F., Takaki, K. S., and Yevich, J. P. (1999). "Preparation of Benzofuran and Dihydrobenzofuran Melatonergic Agents." U.S. Patent 99-5856529.
16. Chen, C.-S., Fujimoto, Y., Girdaukas, G., and Sih, C. J. (1982). Quantitative analyses of biochemical kinetic resolutions of enantiomers. J. Am. Chem. Soc. 104, 7294-7299.
17. Cole, D. C. (1994). Recent stereoselective synthetic approaches to β-amino acids. Tetrahedron 32, 9517-9582.
18. Crosby, J. (1991). Synthesis of optically active compounds: A large-scale perspectives. Tetrahedron 47, 4789-4846.
19. Weijers, C. A. G. M. (1997). Enantioselective hydrolysis of aryl, alicyclic and apliphatic epoxides by Rhodotorula glutinis. Tetrahedron: Asymmetry 8, 639-647.
20. Wilson, C., Wilson, S., Piercy, V., Sennitt, M. V., and Arch, J. R. S. (1984). The rat lipolytic beta-adrenoceptor: studies using novel β-adrenoceptor agonist. Eur. J. Pharmacol. 100, 309-319.
21. Wong, C.-H., and Whitesides, G. M. (1994). "Enzymes in Synthetic Organic Chemistry." Tetrahedron Organic Chemistry Series, Vol. 12. Elsevier, New York.
22. Zhang, J., Reddy, J., Roberge, C., Senanayake, C., Greasham, R., and Chartrain, M. (1995). Chiral bioresolution of racemic indene oxide by fungal epoxide hydrolases. J Ferment. Bioeng. 80, 244-246.